Hospital
Flushing Hospital & Medical Center
Flushing Hospital & Medical Center was paid $52.79M by Medicaid between Jan 2018 and Dec 2024, across 301 billing codes. Its largest line is 90832, psychotherapy session, about 30 minutes — 17% of everything it billed.
33Billing provider infoFLUSHING HOSPITAL & MEDICAL CENTER
FLUSHING, NY 11355
FLUSHING, NY 11355
33aNPI1154461622assigned 02/07/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$52.79M
24GClaims858,737
24DCodes billed301
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#28 of 231
Median peer was paid$561K
This provider vs. median94×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,518 | $263K | |
| 2019 | 68,539 | $2.52M | |
| 2020 | 134,474 | $5.73M | |
| 2021 | 173,058 | $7.94M | |
| 2022 | 167,252 | $16.50M | |
| 2023 | 176,769 | $12.75M | |
| 2024incomplete | 131,127 | $7.09M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 17% | 61,787 | 30,654 | $9.20M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 55,213 | 45,595 | $7.79M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 27,483 | 25,689 | $6.49M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.3% | 13,644 | 13,090 | $3.32M |
| 36415 | Collection of venous blood by venipuncture | 5.5% | 105,257 | 37,261 | $2.91M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.1% | 11,330 | 10,806 | $2.18M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.1% | 17,775 | 15,701 | $2.18M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.9% | 14,730 | 12,466 | $2.07M |
| 80053 | Comprehensive metabolic panel | 3.2% | 60,043 | 18,685 | $1.68M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.2% | 7,839 | 7,011 | $1.18M |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.0% | 6,761 | 6,553 | $1.06M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.5% | 6,914 | 6,903 | $802K |
289 more codes
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.5% | 17,903 | $797K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 4,192 | $501K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 9,367 | $463K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 1,701 | $411K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 4,648 | $389K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 2,625 | $380K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 8,980 | $327K |
| 99285 | Emergency room visit (most serious) | <1% | 1,465 | $315K |
| G0378 | Hospital observation service, per hour | <1% | 277 | $291K |
| 90461 | <1% | 7,675 | $272K | |
| 81025 | <1% | 13,977 | $272K | |
| 76818 | <1% | 3,546 | $270K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,622 | $263K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 2,274 | $260K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 7,180 | $240K |
| 58558 | <1% | 148 | $229K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,363 | $213K |
| 76820 | <1% | 6,222 | $182K | |
| 86850 | <1% | 4,545 | $175K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,087 | $175K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,432 | $172K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,331 | $158K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 5,727 | $157K |
| 80050 | General health panel | <1% | 6,714 | $147K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 1,484 | $142K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 639 | $135K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 122 | $128K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,695 | $126K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,809 | $115K |
| 92557 | <1% | 1,360 | $112K | |
| HZ2ZZZZ | <1% | 286 | $111K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,154 | $109K |
| 76801 | <1% | 1,378 | $106K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,079 | $103K |
| 88307 | <1% | 631 | $100K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 459 | $98K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 615 | $96K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,059 | $91K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 642 | $90K |
| 92587 | <1% | 1,447 | $82K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 711 | $82K |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 4,994 | $79K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 31 | $77K |
| 47562 | <1% | 37 | $73K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,132 | $72K |
| 90686 | <1% | 9,413 | $71K | |
| 92567 | <1% | 2,352 | $68K | |
| Q3014 | Telehealth originating site facility fee | <1% | 3,748 | $64K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 1,428 | $64K |
| 86481 | <1% | 1,349 | $62K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 3,204 | $62K |
| 90651 | <1% | 1,023 | $61K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 434 | $60K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 456 | $60K |
| 86901 | <1% | 4,553 | $60K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 404 | $58K |
| 99205 | Prolong outpt/office vis | <1% | 213 | $56K |
| 83655 | <1% | 3,973 | $53K | |
| 90677 | <1% | 1,227 | $53K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 5,004 | $51K |
| 86900 | <1% | 4,535 | $51K | |
| 90715 | <1% | 2,328 | $51K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,223 | $50K |
| 88720 | <1% | 2,533 | $49K | |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | <1% | 387 | $44K |
| 90746 | <1% | 502 | $42K | |
| 76830 | Ultrasound, transvaginal | <1% | 611 | $42K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 548 | $41K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 441 | $41K |
| 76813 | <1% | 587 | $40K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,789 | $39K |
| 80061 | Lipid panel | <1% | 5,028 | $34K |
| 86580 | <1% | 1,760 | $34K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 19,594 | $33K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 362 | $33K |
| 88142 | <1% | 1,212 | $33K | |
| 99051 | <1% | 1,673 | $32K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 167 | $32K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 452 | $31K |
| 54161 | <1% | 27 | $30K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 189 | $29K |
| 99408 | <1% | 522 | $28K | |
| 90697 | <1% | 1,206 | $28K | |
| 90670 | <1% | 4,147 | $27K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,616 | $27K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 131 | $27K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 207 | $26K |
| 88304 | <1% | 1,043 | $24K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,520 | $24K |
| J2704 | Injection, propofol, 10 mg | <1% | 7,531 | $23K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,758 | $22K |
| 85610 | <1% | 7,770 | $22K | |
| 81001 | <1% | 9,627 | $21K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 691 | $21K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 686 | $20K |
| 99402 | <1% | 232 | $19K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 37 | $19K |
| 87088 | <1% | 5,438 | $18K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 160 | $18K |
| 85730 | <1% | 6,538 | $17K | |
| H0038 | Self-help/peer services, per 15 minutes | <1% | 651 | $17K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 449 | $15K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 618 | $15K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,936 | $15K |
| 90648 | <1% | 2,976 | $14K | |
| 76641 | <1% | 196 | $13K | |
| 0071A | <1% | 68 | $12K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 313 | $12K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,710 | $12K |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | <1% | 983 | $11K |
| 12001 | <1% | 42 | $11K | |
| 0072A | <1% | 61 | $11K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,416 | $11K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 182 | $11K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 384 | $11K |
| 94060 | <1% | 290 | $10K | |
| 86803 | <1% | 1,195 | $10K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 5,537 | $9K |
| 76770 | <1% | 40 | $9K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 682 | $9K |
| 90723 | <1% | 1,943 | $9K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 6,167 | $9K |
| 80076 | <1% | 1,350 | $9K | |
| 90633 | <1% | 2,014 | $9K | |
| 92579 | <1% | 189 | $8K | |
| 84480 | <1% | 1,261 | $8K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 281 | $7K |
| 87150 | <1% | 111 | $7K | |
| 71045 | Radiologic examination, chest; single view | <1% | 3,046 | $7K |
| 94726 | <1% | 176 | $7K | |
| 0001A | <1% | 178 | $7K | |
| 84436 | <1% | 1,409 | $7K | |
| 94729 | <1% | 260 | $6K | |
| 90381 | <1% | 39 | $6K | |
| 90698 | <1% | 1,415 | $6K | |
| 90656 | <1% | 1,048 | $6K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 186 | $6K |
| 87077 | <1% | 1,065 | $6K | |
| 0002A | <1% | 153 | $6K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 99 | $5K |
| 90681 | <1% | 3,091 | $5K | |
| 76825 | <1% | 26 | $5K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 986 | $5K |
| H2010 | Comprehensive medication services, per 15 minutes | <1% | 43 | $5K |
| 83880 | <1% | 288 | $5K | |
| 92555 | <1% | 98 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,318 | $4K |
| 90707 | <1% | 1,754 | $4K | |
| 76536 | <1% | 53 | $4K | |
| 97116 | <1% | 66 | $4K | |
| 86800 | <1% | 393 | $4K | |
| 97010 | <1% | 196 | $4K | |
| 84702 | <1% | 1,149 | $4K | |
| 74018 | <1% | 1,081 | $4K | |
| 84479 | <1% | 1,110 | $4K | |
| 87081 | <1% | 334 | $4K | |
| 82947 | <1% | 3,241 | $3K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 925 | $3K |
| 86376 | <1% | 240 | $3K | |
| 86706 | <1% | 375 | $3K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 4,610 | $3K |
| 87070 | <1% | 1,505 | $3K | |
| 90716 | <1% | 1,753 | $3K | |
| 94760 | <1% | 3,418 | $3K | |
| 81514 | <1% | 12 | $3K | |
| 87340 | <1% | 1,327 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,410 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,201 | $3K |
| 93970 | <1% | 26 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 88 | $2K |
| 87400 | <1% | 1,080 | $2K | |
| 97014 | <1% | 190 | $2K | |
| 84439 | <1% | 360 | $2K | |
| 73562 | <1% | 286 | $2K | |
| A0429 | Emergency ambulance ride, basic life support | <1% | 43 | $2K |
| 84432 | <1% | 144 | $2K | |
| 98968 | <1% | 46 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 4,336 | $2K |
| 83690 | <1% | 4,206 | $2K | |
| 86003 | <1% | 54 | $2K | |
| 84484 | <1% | 3,245 | $2K | |
| 80320 | <1% | 2,032 | $2K | |
| 90619 | <1% | 98 | $2K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 2,628 | $2K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 2,504 | $2K |
| 86592 | <1% | 1,814 | $2K | |
| 36416 | <1% | 330 | $2K | |
| 92650 | <1% | 14 | $2K | |
| 82550 | <1% | 2,855 | $2K | |
| 90756 | <1% | 60 | $2K | |
| 81003 | <1% | 1,808 | $2K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 2,490 | $2K |
| 76775 | <1% | 53 | $2K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 4,535 | $2K |
| 90380 | <1% | 48 | $2K | |
| 87040 | <1% | 2,382 | $2K | |
| 83735 | <1% | 2,587 | $1K | |
| 82950 | <1% | 451 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,363 | $1K |
| 94761 | <1% | 7,875 | $1K | |
| 92586 | <1% | 12 | $1K | |
| 82728 | <1% | 179 | $1K | |
| 82150 | <1% | 2,450 | $1K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,758 | $1K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 143 | $1K |
| 76827 | <1% | 26 | $1K | |
| 97803 | <1% | 26 | $1K | |
| 90700 | <1% | 931 | $1K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 1,013 | $1K |
| 82043 | <1% | 190 | $1K | |
| 90732 | <1% | 12 | $1K | |
| 92552 | <1% | 26 | $1K | |
| 85651 | <1% | 1,126 | $1K | |
| 85027 | <1% | 2,992 | $1K | |
| 86704 | <1% | 133 | $1K | |
| A0425 | Ground mileage, per statute mile | <1% | 452 | $1K |
| 97802 | <1% | 12 | $1K | |
| 73610 | <1% | 208 | $1K | |
| 83021 | <1% | 45 | $1K | |
| 93325 | <1% | 36 | $1K | |
| 86140 | <1% | 2,108 | $1K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 26 | $941.31 |
| 83605 | <1% | 1,933 | $897.25 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 573 | $880.16 |
| 94727 | <1% | 27 | $867.21 | |
| 86703 | <1% | 59 | $854.06 | |
| 86762 | <1% | 133 | $852.94 | |
| 87186 | <1% | 399 | $784.62 | |
| 85007 | <1% | 2,809 | $710.91 | |
| 84550 | <1% | 223 | $699.33 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 924 | $699.33 |
| 84100 | <1% | 1,531 | $640.31 | |
| 84403 | <1% | 30 | $619.44 | |
| 73630 | <1% | 163 | $544.79 | |
| 87807 | <1% | 190 | $536.77 | |
| A4648 | Tissue marker, implantable, any type, each | <1% | 15 | $484.50 |
| 92015 | Determination of refractive state | <1% | 26 | $460.68 |
| 90696 | <1% | 465 | $452.91 | |
| 82962 | <1% | 389 | $415.55 | |
| 90662 | <1% | 13 | $408.62 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 14 | $407.23 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 12 | $403.80 |
| 70360 | <1% | 15 | $387.66 | |
| 83001 | <1% | 25 | $351.16 | |
| 36600 | <1% | 19 | $345.62 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,217 | $342.13 |
| 96376 | <1% | 48 | $294.70 | |
| 82553 | <1% | 379 | $288.84 | |
| 92550 | <1% | 13 | $283.01 | |
| 90620 | <1% | 68 | $275.04 | |
| 90734 | <1% | 393 | $273.86 | |
| 86769 | <1% | 14 | $265.95 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 830 | $262.23 |
| 84402 | <1% | 12 | $254.70 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 461 | $243.73 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 77 | $237.08 |
| 84146 | <1% | 13 | $232.56 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 528 | $231.37 |
| 73130 | <1% | 60 | $194.63 | |
| 85379 | <1% | 247 | $190.25 | |
| V2632 | Posterior chamber intraocular lens | <1% | 16 | $168.59 |
| 86787 | <1% | 25 | $161.56 | |
| 73110 | <1% | 52 | $145.28 | |
| 73140 | <1% | 27 | $131.08 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 213 | $112.17 |
| 73030 | <1% | 15 | $111.50 | |
| 84703 | <1% | 83 | $108.93 | |
| 86038 | <1% | 27 | $93.60 | |
| 83550 | <1% | 27 | $90.54 | |
| 72100 | <1% | 14 | $90.02 | |
| 88300 | <1% | 27 | $84.48 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 1,746 | $83.84 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 136 | $78.93 |
| 83615 | <1% | 94 | $65.49 | |
| 87634 | <1% | 12 | $64.29 | |
| 90685 | <1% | 71 | $55.17 | |
| 86403 | <1% | 37 | $39.53 | |
| 80348 | <1% | 25 | $35.00 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 78 | $32.20 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 145 | $22.70 |
| 96367 | <1% | 26 | $13.06 | |
| 82570 | <1% | 12 | $11.71 | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 15 | $1.28 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 41 | $0.00 |
| 99080 | 0% | 111 | $0.00 | |
| 88302 | 0% | 13 | $0.00 | |
| 73080 | 0% | 14 | $0.00 | |
| 80329 | 0% | 73 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDOSS, MOUNIR (EXECUTIVE VP/CFO)
| Provider | Location | Paid |
|---|---|---|
| Jamaica Hospital | Richmond Hill, NY | $178.14M |
| Jamaica Hospital | Jamaica, NY | $37.88M |
| Jamaica Hospital | Jamaica, NY | $27.88M |
| Flushing Hospital & Medical Center | Flushing, NY | $18.18M |
| Advanced Center for Psychotherapy, INC. | Jamaica, NY | $15.08M |
| Jamaica Hospital Medical Center | Jamaica, NY | $1.42M |
| Medisys Ambulance Service INC | Jamaica, NY | $1.38M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.